Group 1 - The core viewpoint of the article is that Tai Ling Pharmaceutical (01011) is transforming into an artificial intelligence high-tech medical enterprise to adapt to market changes and the widespread application of AI in healthcare [1] - The company has been operating in the healthcare sector for 30 years, demonstrating extensive management experience and a strong medical network [1] - The first phase of the transformation will focus on creating a comprehensive intelligent health ecosystem platform for bone health, covering the entire cycle of "detection, treatment, and rehabilitation" [1]